McDermott Represents Option Care Health in $3.6 Billion Merger with Amedisys - McDermott Will & Emery

McDermott Represents Option Care Health in $3.6 Billion Merger with Amedisys


International law firm McDermott Will & Emery represented Option Care Health, Inc., the nation’s largest independent provider of home and alternate site infusion services, in its $3.6 billion definitive merger agreement to combine with Amedisys, Inc., a leading provider of home health, hospice and high-acuity care. Combining Option Care Health’s complementary home and alternate site infusion services with Amedisys’ home health, hospice, palliative and high-acuity care services will create a leading, independent platform for home and alternate site care.

The transaction was announced on May 3, 2023 and is expected to close in the second half of 2023, subject to approval by Option Care Health and Amedisys stockholders and other customary closing conditions, including receipt of applicable regulatory approvals.

The McDermott team was led by John Tamisiea, Ann Marie Brodarick, James Cannatti, Sarah Kitchell and Ted Diskant and included Jack Beauchamp, Brandon Sarkauskas, Rebecca Trickey, Daniel Gottlieb, Deepali Doddi, Sandra DiVarco, Andrew Kratenstein, Danielle Scheer, Stephania Sanon, Cristell Fortune, Emily Cook, Steven Schnelle, Jennifer Levengood, Jed Gordon, Ellie Atkins, Tony Maida, Patrick Ryan, Dan O’Neil, Traci Ottenfeld, Niraj Patel and Deepak Tamasker.

Read Option Care Health’s press release here.

About McDermott

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

Media Contacts